Abstract LB-295: Detection of oncogenic kinase mutations in circulating plasma DNA and correlation with clinical benefit in the phase III GRID study of regorafenib vs placebo in TKI-refractory metastatic GIST

MLA

Michael F. Leahy, et al. “Abstract LB-295: Detection of Oncogenic Kinase Mutations in Circulating Plasma DNA and Correlation with Clinical Benefit in the Phase III GRID Study of Regorafenib vs Placebo in TKI-Refractory Metastatic GIST.” Cancer Research, vol. 73, Apr. 2013, p. LB-295. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........708a78fd96355b006bd202d4d9c142d9&authtype=sso&custid=ns315887.

APA

Michael F. Leahy, Heikki Joensuu, Sebastian Bauer, Margaret von Mehren, Yoon-Koo Kang, Michael Jeffers, George D. Demetri, Axel Le Cesne, Iris Kuss, Peter Hohenberger, Robert G. Maki, D. Laurent, Binh Bui Nguyen, Piotr Rutkowski, Jean-Yves Blay, Christian Kappeler, Jianming Xu, Martin E. Blackstein, Peter Reichardt, … Paolo G. Casali. (2013). Abstract LB-295: Detection of oncogenic kinase mutations in circulating plasma DNA and correlation with clinical benefit in the phase III GRID study of regorafenib vs placebo in TKI-refractory metastatic GIST. Cancer Research, 73, LB-295.

Chicago

Michael F. Leahy, Heikki Joensuu, Sebastian Bauer, Margaret von Mehren, Yoon-Koo Kang, Michael Jeffers, George D. Demetri, et al. 2013. “Abstract LB-295: Detection of Oncogenic Kinase Mutations in Circulating Plasma DNA and Correlation with Clinical Benefit in the Phase III GRID Study of Regorafenib vs Placebo in TKI-Refractory Metastatic GIST.” Cancer Research 73 (April): LB-295. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........708a78fd96355b006bd202d4d9c142d9&authtype=sso&custid=ns315887.